...
首页> 外文期刊>Biotechnology & Biotechnological Equipment >Dental implant survival and success rate after sinus augmentation with deproteinized bovine bone mineral and platelet-rich plasma at one and five years: a prospective-controlled study
【24h】

Dental implant survival and success rate after sinus augmentation with deproteinized bovine bone mineral and platelet-rich plasma at one and five years: a prospective-controlled study

机译:脱蛋白牛骨矿物质和富血小板血浆充盈窦后一年和五年的种植牙存活率和成功率:一项前瞻性对照研究

获取原文
           

摘要

ABSTRACT The aim of this comparative study was to evaluate, at one and five years, the implant success rate in the resorbed maxilla after sinus augmentation with platelet-rich plasma (PRP)/deproteinized bovine bone mineral (DBBM) versus DBBM/collagen membrane (CM). Using a split-mouth design, 10 patients with ?¢???¤5????mm of residual alveolar bone were treated with PRP/DBBM or DBBM/CM. After eight months, a total of 22 and 21 implants (Osseospeed?¢???¢, Astra Tech AB, Sweden) were inserted in the PRP/DBBM and DBBM/CM sites, respectively. The implant success and survival rates, modified plaque and bleeding indices, probing depth and changes in bone level were all evaluated one year later, and again five years later. Only one implant was lost before the prosthetic rehabilitation of the PRP/DBBM group. There were no statistically significant differences in the evaluated parameters for the 1- and 5-year follow-up in the two groups ( p > 0.05). After five years of loading, no further implants were lost, giving it an overall success rate of 83%. The clinical study showed that a high implant success and survival rate can be achieved at one year and maintained for up to five years, after a sinus-lift procedure utilizing both combinations.
机译:摘要这项比较研究的目的是评估用富血小板血浆(PRP)/脱蛋白牛骨矿物质(DBBM)与DBBM /胶原蛋白膜进行窦道增大后窦再吸收的上颌骨植入成功率(厘米)。采用裂口设计,用PRP / DBBM或DBBM / CM治疗10例残留≥5mm的牙槽骨。八个月后,分别在PRP / DBBM和DBBM / CM部位分别插入了22个和21个植入物(OsseospeedTM,瑞典Astra Tech AB)。一年后和五年后均评估了植入物的成功率和存活率,斑块和出血指数,探查深度和骨水平变化。在PRP / DBBM组修复后,仅丢失了一个植入物。两组的1年和5年随访的评估参数没有统计学上的显着差异(p> 0.05)。经过五年的加载,没有损失更多的植入物,总体成功率为83%。临床研究表明,在使用两种组合进行鼻窦提升手术后,一年内就可以实现很高的植入物成功率和存活率,并且可以维持长达五年。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号